Hanmi Pharm. Co., Ltd. (KRX: 128940)
South Korea
· Delayed Price · Currency is KRW
238,000
+4,000 (1.71%)
Feb 3, 2025, 9:00 AM KST
Hanmi Pharm. Revenue
Hanmi Pharm. had revenue of 362.08B KRW in the quarter ending September 30, 2024, a decrease of -0.70%. This brings the company's revenue in the last twelve months to 1.57T, up 10.32% year-over-year. In the year 2023, Hanmi Pharm. had annual revenue of 1.49T with 11.97% growth.
Revenue (ttm)
1,566.25B
Revenue Growth
+10.32%
P/S Ratio
2.04
Revenue / Employee
672.21M
Employees
2,330
Market Cap
3,189.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,490.89B | 159.34B | 11.97% |
Dec 31, 2022 | 1,331.55B | 128.36B | 10.67% |
Dec 31, 2021 | 1,203.19B | 127.33B | 11.84% |
Dec 31, 2020 | 1,075.85B | -37.80B | -3.39% |
Dec 31, 2019 | 1,113.65B | 97.69B | 9.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics Co.,Ltd. | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience Co.,Ltd. | 201.30B |
Hanall Biopharma | 134.24B |
Hanmi Science | 1,283.65B |
Daewoong Pharmaceutical | 1,416.63B |